{
  "author": {
    "name": "Robert Langreth Benjamin Elgin",
    "webUrl": "/author/profile/robert-langreth-benjamin-elgin/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2017/12/27/drug-companies-relationships-with-patient-assistan/",
        "title": "Drug companies' relationships with patient-assistance charities under scrutiny",
        "byline": " Robert Langreth, Benjamin Elgin ",
        "kicker": "",
        "prettyDate": "December 27, 2017",
        "timeToRead": "6 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/robert-langreth-benjamin-elgin/",
            "name": "Robert Langreth, Benjamin Elgin"
          }
        ],
        "kickerNode": [],
        "summary": "For the past two years federal regulators have issued subpoenas and scrutinized relationships between drug companies and the charities, which are supposed to operate independently from industry donors.",
        "body": null
      }
    ]
  }
}